- Motley Fool•15 hours ago
Diabetes patients could have new treatment options if Merck, Pfizer, Lexicon, Sanofi, and Novo Nordisk succeed with these three promising drugs.
- Business Wire•2 days ago
Attorney Advertising. On March 17, 2017, the nationally recognized class-action law firm of Keller Rohrback L.L.P. filed suit against the nation’s three largest pharmacy benefit managers , Express Scripts , OptumRx , and CVS Caremark , and the three major insulin manufacturers, Sanofi-Aventis , Novo Nordisk , and Eli Lilly , who produce the well-known and widely-prescribed analog insulins: Lantus, ...
- Investor's Business Daily•2 days ago
Sanofi makes sense as an acquirer for Flexion Therapeutics, an analyst said Friday, but Flexion investors were dubious.
SNY : Summary for Sanofi American Depositary Shar - Yahoo Finance
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||44.50 - 44.81|
|52 Week Range||36.81 - 45.13|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||23.07|
|Dividend & Yield||1.58 (3.53%)|
|1y Target Est||N/A|